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One of the important discoveries in reproduction is
that the reproductive process uses for its own pur-
pose lymphokines and cytokines which were ini-
tially defined as being of immunologic nature, first
traced within the immune system. This is not very
surprising, since most of these molecules are more
signaling factors and communication molecules be-
tween cells of various lineages than molecules
strictly restricted to the immune system, such as
immunoglobulins (Ig) and T-cell receptors. The
field has now evolved from the idea of a host-graft
relationship to the concept of an integrated dia-
logue between the mother and the conceptus,
more akin, for some, to a host-tumour relationship.
Yet, in fact, the paradigm of acceptance and/or re-
jection of the foetus by its mother is still heavily
embedded in the thinking of many reproductive
immunologists.
This is not surprising, since the trend of research
that led to modern reproductive immunology was
initiated by Sir Peter Medawar’s disquisition on
"the riddle of the foetal allograft. ’’1 It is therefore
not all disconcerting that, in 1997, one of Me-
dawar’s colleagues, Leslie Brent, in his recent book
A History ofTransplantation Immunology, still depicts
the materno-fetal relationship as "Nature’s (al-
most) perfect allograft, ’’z nor that pioneering work
in the field is due to another collaborator of Leslie
Brent and Peter Medawar, Rupert E. Billingham.
3
However, the paradigms have evolved. As you
will see in this brief presentation, there is still room
for discussing, and re-envisaging, with the use of
murine models and data in humans, the concept
and mechanisms of "rejection" of the foetal allo-
graft.
But the question of the tolerance of the concep-
tus has evolved. First, we have known for a long
time that we can and must dissociate local and sys-
temic events, but this idea has not yet fully pen-
etrated the thinking of the general public.
It is possible to observe rejection of paternal
strain tissues after preimmunisation of the mother
without compromising pregnancy4,s (in fact, the
babies born in such situations are in most circum-
stances heavier), and we have personally verified
that.6
It ensues that systemic immune responses
(which we do not want at all to negate, having
taken a rather indisputable part in their discovery7)
are, at best, a testimony of maternal recognition of
the foeto-placental unit.
Indeed, pregnancy is perfectly possible in the
absence of humoral (antibody) response, s,9 Indeed,
if tolerance to the foetus was alloantibody medi-
ated, it would be an exception, because tolerance is
MHC restricted, and the Nobel prize awarded to
Zinkernagel and Doherty recognizes the conse-
quences of that phenomenon. With rare excep-
tions, antibodies are not MHC restricted, and at-
tempts to say that tolerance was antibody mediated
should be in immunology history. This is not com-
pletely true, since there is not yet a satisfactory
explanation of the enhancement phenomenon,
possibly because of the controversy over IgG1/
IgG2 in mice, which uselessly shifted the debate-
enhancing antibodies in rats, are part cytotoxic.
Similarly, we do not negate, of course, the exis-
tence of systemic suppresser cells,7 but pregnancy
is perfectly viable in animals experimentally de-
pleted of these.1
The repeated enunciation in France that preg-
nancy depends on an alloantibody and suppresser
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T-cell-mediated immune response is simply out-
dated since around 1979-1981, and claims that
unfortunately are expressed in mainstream immu-
nology meetings and in print that "reproductive
immunology has to teach the mainstream immu-
nologists how the immune system works" as a "fa-
cilitation reaction" with "important role for en-
hancing antibodies.., and suppresser cells" have
disastrous effects:
First, mainstream immunologists repeatedly dis-
miss, in a more and more irritated fashion, such
preposterous advances, and, as such, would con-
sider as a backlash the whole field as not serious;
Second, those claims have led some clinicians to
exacerbate the role of maternal antibodies,
clouding unconsciously the issue of early preg-
nancy loss.
Third, they distract from the main advances that
have indeed been going on, leading to molecular
understanding of the field.
For indeed, there has been progress, such as
Tom Wegmann’s seminal idea that possibly we
should re-envisage our view of the immune system
in pregnancy: instead of seeing the foetus as con-
fronted by a threat of rejection by its mother--the
"immunotrophic" concept postulated from a dis-
covery made with the routine abortion model (the
CBA DBA/2 system), 11,1z we recognize that im-
mune reaction could be in some cases beneficial for
fetal survival. 13
Then, it ensued the demonstration in vitro, then
in vivo, that indeed T-cell derived cytokines were
growth factors for the placental trophoblasts, 14 fol-
lowed by in vivo demonstration of T-cell control of
placental growthls,6 and treatment of a murine
abortion model (CBA x DBA/2) by purified or re-
combinant cytokines.7
In the very same period, David Clark had made
the discovery that this precise model (CBA x DBA/
2) was deficient in local, decidual associated sup-
presser factor,
8 and later on showed that this factor
was molecularly related to TGF-b2.19
We are now faced with events occurring mostly
locally, and with the concept of a cytokine network
at the foeto-placental interface. The events are in
fact different whether one looks at parturition
(where there is good evidence for involvement of
interleukin [ILl-l, IL-6, IL-8, and tumor necrosis
factor [TNF]e-z,zs) or the established pregnancy
which is indeed immunologically characterised by
transient acceptance of relatively weakly immuno-
genic tumor grafts of parental strain origin in the
first pregnancy, linked to a T-cell anergy state and
suppresser T-cell mediated multi-pregnancy in-
duced tolerance to paternal alloantigens.26-29
In the latter case, the close examination by poly-
merase chain reaction (PCR) of cytokine profiles
shows that it is more complicated than initially
thought, with variations throughout pregnancy of
which the physiological significance is yet un-
clear,
3 and which we will not detail here in the
human. Similarly, the profiles are not simple in
mice. 131
And we now come to the topic of this commu-
nication, early pregnancy. Nowhere is the under-
standing of the cytokine network more interesting,
and nowhere has it led to more surprising discov-
eries, opposed to the paradigm of the acceptance of
the foetal allograft, and so far away from the initial
framework (which aas indeed once useful) of the
facilitation reaction.
Early implantation requires "inflammatory"
molecules, the consequence, in part, of a quasi-
inflammatory reaction locally, followed by an im-
mediate return to non-inflammatory conditions. It
is probable, from what we know in animal models,
that each of these steps are absolutely required for
further successful pregnancy. But before that, a
word is required about the antigenicity of the em-
bryo in mice and humans.
AN ALLOGRAFT?
It is a tautology, a "Lapalissade" to say that to be
alloantigenic, an embryo must express foreign tis-
sues antigens. This is not totally true. Failure to
express major histocompatibilty antigens has an-
other counterpart. It activates cells which are what
Charlie Loke calls the most primitive immune sys-
tem,
31 the Natural Killer cells (NKs). That it was so
is a relatively recent discovery, which owes a lot to
the theory of the "missing self" originally proposed
by Klas Karre.3z Therefore, it ensues that the tro-
phoblasts cannot theoretically be completely neu-
tral, otherwise there would be an NK-mediated re-
jection reaction: the NKs express two sorts of re-
ceptors, which are not yet fully understood, albeit
an impressive body of evidence is accumulating
(see Immunological Reviews 158). Killer Activat-
ing Receptors (KARs), whose engagement, in a
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neoclassical fashion, triggers NK lytic pathways
(and possibly others, such as cytokine secretion,
especially when the Killer Inhibitory Receptors
[KIRs] are engaged). The second, and most impor-
tant, are KIRs. The KIRs arc activated when en-
gaged by the reconnaissance of the presence of
MHC molecules (most often in a given minor histo-
compatibility antigen context), which explains "eas-
ily" some "oddities" which we published for the
sake of honesty on the CBA xDBA/2, system and
which were then rejected by proponents of the
MHC-T-cell duo theory (proponents for whom we,
incidentally, have the greatest respect), triggered
so as to inhibit NK lytic pathway.
An added level of complexity for immunologists
and clinicians is that while MHC is (relatively) con-
served through evolution as a member of the super
Ig family, KIRs and KARs are not at all related
between mice and humans. Why?
Somehow, the trophoblast faces a dilemma: ex-
press MHC, which might trigger a classical. T-cell-
derived rejection reaction, or repress completely
MHC, which will defuse the KIRs and trigger NK-
mediated rejection.
This dilemma is partly solved in the human.
The trophoblast expresses, as far as its extravillous
component is concerned, a specific antigen, HLA-
G, with no variations (or a few amino acids) from
one individual to the other, but it is now known
that it has some variability.3s HLA-G has little pep-
tide presenting capacity (but it does have it!), and,
as a truncated molecule, it is not recognised as
"polymorphic." (It has few antigenic disparities
between individuals, if any, that can be "seen" by
T-cell receptors, whereas it certainly inhibits NK
function. Recent experiments by Strominger,
Lopez Bottet et al, Ramensee, and Le Bouteiller
confirm the earlier ones of Kovatts and
Loke.36,37,38)
The situation would thus seem simple in hu-
mans: the extravillous trophoblast is where interac-
tion with decidual lymphocytes takes place and
therefore where NK and NK-like cells accumulate
and are defused. The lack of classical MHC mol-
ecules would render the trophoblast a non-target
and a non-inductor of a classical T-cell-mediated
response. In addition, there is no bioactive IL-2 in
decidua, albeit an IL-2-1ikc material has been
traced.39
The situation is more complex than that, even
for those who would like to make an exception in
the case of primates: in humans, the expression of
HLA-G is restricted to extravillous cytotropho-
blasts, villous cyto-, and syncytiotrophoblasts that
are uniformly MHC-negative, but a mirror situa-
tion is observed in baboons, and in the rhesus mon-
key, HLA-G homologue is a pseudo gene (al-
though its function could be exerted by a yet un-
characterised protein).4,41 So, this is already a snag.
Two further snags are to be discussed: First,
how could the totally MHC-negative human syncy-
tiotrophoblast, a fact not dismissed since its de-
scription by Faulk,4z,43 not trigger NK-mediated
lysis? This is as yet unexplained by proponents of
the HLA-G paradigm. Second, we now know that
HLA-C is expressed by extravillous trophoblast.37
It has a restricted polymorphism and interacts with
NKs, but the theory must somehow be twisted to
make it act as purported for the monomorphic
HLA-G, for despite a certain paucity of reports,
there are T-cell-mediated responses to HLA-C.
Finally, in all species other than the primates,
there is expression of classical, polymorphic class I
molecules, generally precisely on the layers of the
placenta that confront the maternal immune sys-
tem (44,45,46). In mice K, D, and L are expressed
on the spongiotrophoblast, perfectly accessible to
antibodies and cells. The same is true in horses for
equine leukocyte antigens, in pigs for swine leu-
kocyte antigens, and, according to Twink Allen, in
elephants.
There are three alternative hypotheses for the
problem:
One is that man is man, or, as Peter Johnson
wrote (The Immunologist, 1996:4;p172), "differ-
ences in placentation between humans, rodents,
and other species can make direct comparisons
largely meaningless."
The second one is, as Leslie Brent says when
discovering the status of HLA-G in other spe-
cies, that HLA-G suppresses as would any
proper MHC-ligand in the proper cells (that is,
by the sort of experiments in which the missing
self was discovered to be true) and that HLA-G
has likely another function, since there is no
equivalent in mice, etc, that warrants its evolu-
tionary appearance (a specific peptide or hor-
mone intracellular carrier, for example, yet un-
covered).
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The third one is that there are in other species
functional equivalents of HLA-G, which could re-
side in the already discovered monomorphic or
poorly polymorphic MHC class molecules.
None of these theories, incidentally, is mutually
exclusive.
However, for class II (I-a in mice, HLA-DR in
humans), the situation is more simple. In no spe-
cies do the trophoblast layers express, class II al-
loantigens, and expression of class II on tropho-
blasts induced by azacytidine results in regular
abortion in mice.47
Why? The question is unsettled, since the
mechanisms have not been explored, but one
should recall here in the same vein that expression
of class I in mice is restricted to spongiotropho-
blast, with no expression being found on labyrinth.
Indeed, derepression of class I expression in the
labyrinth is found in interferon y induced abortion,
but one does not know if it is a consequence or a
cause of abortion.48 So, we are in quicksand about
the "allograft status of the embryo."
As far as the preimplantation embryo is con-
cerned, it is simpler to say that there is no class I
expression (nor class II) whatsoever on the ga-
metes, blastocysts, extracellular cell mass or ecto-
placental cell cone (EPC) in any species, including,
when studies could be done, humans.49 This is
somehow troublesome for some aspects of the re-
cent HLA-G theories: the negative EPC cells cer-
tainly are facing a very important NK accumula-
tion.so And yet, the EPC resists perfectly well NK-
mediated lysis. Conversely, aborted embryos in
many species at that early stage display MHC ex-
pression on EPC cells.
The solution may be simple: at that stage, the
cells of the EPC are intrinsically resistant to cell-
mediated lysis,
sl-s3 most probably because cell-
mediated death involves target cell participation
and the pathways of apoptosis. Like other cells se-
creting high amounts of steroids, trophoblasts are
resistant to steroid-induced apoptosis and thus to
cell-mediated death. However, they are sensitive
to LAKCs mediated cell death,s4 but for that we
will see that there is in addition a lot of immuno-
suppressive material in the vicinity, and that abor-
tion might not be mediated by trophoblast death.
Such an immunosuppression takes place after im-
plantation, which on the contrary calls for inflam-
mation, and is a Thl response.
INFLAMMATION AND IMPLANTATION
In France, the early stages of pregnancy are diffi-
cult to study in humans, despite advances in medi-
cally assisted reproduction. The Loi Huriet re-
quests full informed consent before taking a biopsy
sample, and in the very "sensitive" area of repro-
ductive tract organs, this is quite a deterrent, as
opposed to the ease with which blood samples are
obtained.
In the implantation period, where some events
are very transiently associated with blastocyst ad-
hesion and initial invasion of uterine walls, it is, of
course, inconceivable and unlawful to deliberately
transfer an in vitro fertilisation (IVF) for the sole
purpose of aspiration or, even worse, (total) re-
moval of uterine tissues for immunological investi-
gations. As stated, animal models are not necessar-
ily fully pertinent, and thus Y.W. Loke said at the
15th World Congress on Fertility and Sterility in
Montpellier that the only valid model for human
pregnancy is "the human species itself."
But, this does not solve fully the problem of the
periimplantation period. Macaques are not fully
relevant, because of antigenic disparities, like ba-
boons, at the trophoblast level with human situa-
tion, and chimpanzees are an endangered and pro-
tected species of extremely limited availability. For
these reasons, in vitro alternative models have
been developed, which may or may not be totally
relevant, complemented by studies in animals,
mostly in mice.
Animal Studies
The studies performed in animals have revealed a
salient and totally unexpected aspect contrasting
with the established pregnancy: the preimplanta-
tion uterus undergoes an "inflammatory-like" re-
action, with transient influx, after mating in mice
and rats, there of lymphocytes and macrophages,
and seminal fluid is required, since this is not seen
in females with fallopian tubal ligation or in vasec-
tomised males,ss-s7 As expected, an increased se-
cretion of IL-1 or, IL-1 13, TNF or, IL-6, and mRNA
is detected in the uterus, paralleled by the preg-
nancy-associated continuous rise in production of
CSF-1 which starts by then.ss’s9 Except for CSF-1,
those inflammatory cytokines return to basal levels
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by days 3 and 4, but CSF-1 secretion continues to
increase throughout pregnancy.58,s9 In rats, local
injection of the PAF-acether antagonist BN 50081
completely prevents implantation, whereas the un-
treated contralateral horn is fully receptive,ss,s6
Three cytokines are, in our opinion, crucial, as
established in mutant or "knock-out" animals:
CSFs, IL-1, and LIF.
CSFs (CSF-t, S-CSF,   -CSF)
CSF-1 deficient oSP (osteopetrotic, or op/op) mu-
tant mice have a profound pregnancy defect, and
males have also reproductive functions. CSF-1 re-
ceptor, c-fins, is expressed after the 2-4 cell stage
until the EPC outgrowth and later the spongiotro-
phoblast and is also found at very high levels in the
maternal then the primary decidual zone and fi-
nally in the sole decidua basalis.6z S-CSF and its
receptor (c-kit, which maps in the dominant white
spotting W locus in the mouse), is also important,
since mutations in theW locus t result in sterility in
mice, often associated with abnormal embryonic
development.6z
GM-CSF was the first cytokine with IL-3 in-
volved in the immunotrophic theory13-16 and
is found in the preimplantation uterus. Tarta-
kowsky has shown that culture of CBA x DBA/2
embryos (a murine abortion model11,z) in GM-
CSF- or CSF-l-containing medium partly corrects
the deficient implantation rate seen when trans-
ferring these embryos in CBA/J mothers.63 GM-
CSF receptor is expressed in the EPC and later
spongiotrophoblast cells and in the early implanta-
tion uterus.64’65 Recently, in an elegant series of
experiments, Robertson implied the inflammatory
response and more peculiarly the GM-CSF. In
agreement with studies conducted to prove the im-
munotrophic theory, s,16,66 she found that GM-
CSF-deficient mice have smaller litter sizes and
placental weights than controls and implies GM-
CSF and components in the semen ejaculate in
hyporesponsiveness to paternal alloantigens.67
IL-I
IL-1 might play a mandatory role in pregnancy.
According to Simon and Polan,68 IL-1 receptor an-
tagonist completely prevents successful implanta-
tion in mice. However, Colin Stewart et al. (Stew-
art, personal communication and answers at many
meetings) have examined at the Roche Institute
for Molecular Biology IL-1 deficient mice with per-
fectly normal reproductive function, nor did we ob-
tain implantation failure in mice by in vivo injec-
tion of neutralising anti-IL-1 antiserum.
LIF
By gene knock-out technology, Stewart has el-
egantly shown that maternal production of LIF is
mandatory for successful implantation: LIF-
deficient mice, obtained by "gene knockout" are
fertile, but sterile. LIF-/LIF- embryos implant in
normal CD1 recipient mice, but LIF +/LIF + em-
bryos do not implant in LIF-/LIF- mice. The de-
fect is corrected by recombinant HILDA LIF via
an osmotic pump.
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Human Studies
IL-I
IL-1 a, 13 expression is found in human endome-
trial epithelium throughout the menstrual cycle,
reaching a peak in the late luteal phase.7,7 Immu-
nohistochemistry shows that IL-1 receptor antago-
nist in human endometrial cells is at higher levels
during the follicular phase than during the early
and mid luteal phases.72 IL-1 is also found in tro-
phoblasts and IL-1 receptor type I on syncytiotro-
phoblasts, suggesting an autocrine and paracrine
role of IL-1 in human implantation.7 Indeed, it
has been reported that IL-1 is a modulator of the
decidualisation itself,74 and it is also controlling
hCG production by human trophoblasts in cul-
ture.7 The production and role of IL-1 by early
human embryos is controversial; some authors
made it a predictor of successful implantation in
humans, 76,77 while others did not detect it at
all.34,78 Differences in culture media, conditions,
etc. obviously could be invoked. In a co-culture of
endometrial epithelial cells and or stromal cells
with embryos, IL-1, IL-1 receptor antagonist, and
IL-1 receptor type were found in about 56% of
cells from embryos cultured with epithelial cells
but not stromal cells, apparently correlated with
pregnancy success.79
LIF
LIF is present in human endometrium, with con-
sensus for its expression in the second part of the
cycle, and during pregnancy, this in variance with
mice.8-8z,84 Optimal uterine secretion coincides
with the implantation window and expression of
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TABLE I. Endometrial HILDA/LIF production index in fertile women
Obstetrical status
HILDA/LIF production Number of successful Last pregnancy
index Cycle day Age (years) pregnancies (years)
1.05 20 50 2 18
1.66 6 36 2 4
1.94 14 41 2 20
2.21 10 37 4 5 weeks
2.22 20 41 2
2.28 7 32 2 9
2.35 22 34 2 10
3.16 10 36 12
3.27 18 32
3.39 10 41 5 14
3.85 19 35 2 6 weeks
4.06 19 36 2 12
4.51 22 32 2 4
4.57 37 30 5
6.48 II 38 2 8
9.95 24 41
aMedian 3.22.
bplUS one pregnancy loss before successful pregnancy.
From: Delage G, Moreau J-F, Taupin J-L, et al.: In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant
cultures from fertile and infertile women. Hum Reprod 10:2483-2488, 1995.
LIF receptor by human embryos.8s,86 We have
found women with quantitative defects in LIF pro-
duction;87,88 we have observed such a deficiency in
women with successful IVF but confirmed steril-
ity.87,88 We have now confirmed those data, ob-
tained in a culture system, by both immunohisto-
chemistry, using polyclonal antibodies, and evalu-
ation of LIF production by isolated uterine
epithelial cells.
Tables 1, 2a, 2b, and 3 show typical LIF pro-
duction indexes in fertile and infertile women, as
defined, in an in vitro assay system, by the index of
LIF production by explant cultures in culture su-
pernatants from Day 5 and Day 1. It is interesting
to note that in women whose most recent repro-
ductive event was a pregnancy loss, there are a
great number with a low LIF production index
(Table 3), the indexes being very low for women
with recurrent implantation failure or recurrent un-
explained sterility (Tables 4 and 2b). The exis-
tence of a low producer of LIF has been confirmed
ex vitro by uterine flushing and ELISA assays.
89
As stated above, we wanted to have a totally
objective measure of LIF production in situ by the
human endometrium. We therefore set up the
technique of selective separation digestion of glan-
dular and stromal endometrium, after a Cornier of
Frydman pipette biopsy sample, and using poly-
clonal antibodies raised in cooperation with J Mar-
tal (INRA, France), E. Boosmans (Eurogenetics,
Belgium), and J F. Moreau and J L. Taupin
(CNRS, Bordeaux). Data show that there is always
a specific staining in the glandular cells, though
contaminating cells of this origin can account for
the low number of positive cells in the "stromal"
compartment, which is in fact "negatively se-
lected." One observes, as a result of trypsin diges-
tion, that dead cells are already permeated, thus
accounting for the positive staining seen in the
non-permeated populations. We will give two ex-
periments as examples, values being expressed as
mean fluorescence intensity (which cannot be com-
pared from one experiment to another, of course,
but in the future we will always refer to the positive
clone 8 values). On May 16, 1997, we found a mean
value of 52.75 in an infertile woman, vs. 112.26 and
137.43 in two fertile ones, and on April 10, 1997,
108.75 in the fertile woman, vs. greater than 90.39
in infertile woman number and greater than 37.27
in infertile woman number 2. On May 20, 1997, we
similarly found 401.11 in the fertile woman, vs.
greater than 158.25 in the infertile woman. Though
this technique is somewhat limited by the re-
stricted availability of the rabbit antiserum used
(not all the rabbit anti sera were useable for FACS
analysis, and both an excellent neutralising goat
antiserum that we raised as well as commercial
monoclonals proved unreliable in that respect), we
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TABLE 2A. Endometrial HILDA/LIF production index in infertile women with recurrent implantation failure
HILDA/LIF production Number of IVF Number of Last pregnancy
index Cycle day Age (years) with embryos pregnancies (years)
0.96
0.97
0.97
.01
.22
.41
.49
.68
.69
.70
.74
2.45
10 34 3 (EUP) 15
5 29 20 3 (2 PL, EUP) 5
21 34 8 2 (I EPT, EUP) 4
6 34 2 I(PL) 9
15 35 3 0
10 39 0
18 33 2 0
9 36 6 0
21 36 2 0
7 34 4 0
14 33 4 (EUP) 10
18 38 6 0
aMedian 1.45.
bplUs GIFT.
EUP extrauterine pregnancy; PL pregnancy loss; EPT elective pregnancy termination.
From: Delage G, Moreau J-F, Taupin J-L, et al.: In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant
cultures from fertile and infertile women. Hum Reprod 10:2483-2488, 1995.
TABLE 2B. Endometrial HILDA/LIF production
index in infertile women with unexplained
primary sterility
HIL.DA/LIF production
index Cycle day Age (years)
1.22 12 41
1.28 6 30
1.39 8 30
1.48 6 33
2.70 13 34
aMedian 1.39.
From: Delage G, Moreau J-F, Taupin J-L, et al.: In vitro endometrial
secretion of human interleukin for DA cells/leukaemia inhibitory factor
by explant cultures from fertile and infertile women. Hum Reprod
10:2483-2488, 1995.
believe we have an objective assay that can
complement immunohistochemistry, analysis on
cytofuge smears, and in vitro production in explant
culture.
It is important, in this context, to emphasize that
recombinant human HILDA LIF is available, and
women could benefit from substitutive therapy.
While we feel confident enough to go forward with
such a procedure, the clinicians would prefer we
first correct a defect outside pregnancy before go-
ing further on.
This leads to questions about the mechanisms
of action of LIF and, indeed, the inflammatory re-
sponse. It is our working hypothesis that the local
inflammation is required for optimal expression on
placental trophoblast and uterine decidual cells of
adhesion molecules, which are necessary for im-
plantation to occur, such as trophoblast laminin and
fibronectin receptors, and specifically the o 13 1,
ci 5 13 1, o 6 13 1, and o 6 13 4 integrin heterodimers,
and expression of their receptor molecules (laminin
and fibronectin) in the periimplantation as well as
first trimester uterus with specific trophoblast
down-regulation of expression of the 13 4 integrin
and up-regulation of the 13 1, c 5, o 1 subunits
during the invasion process.91-93
We believe that an important part of early preg-
nancy loss is due to abnormal processes of this early
reaction. It is noticeable that dysregulations are al-
ready known, such as in preeclampsia, where tro-
phoblasts do not down-regulate 13 4, nor is o 1 up-
regulated.94 In addition, the effects of cytokines on
the matrix degrading protease are also to be en-
compassed in that respect.
31
TNF
There is early and temporary expression of rela-
tively high levels of TNF by invading extravillous
trophoblasts9s which could, as seen in other sys-
tems, up-regulate adhesion molecules and selec-
tin.96 This inflammatory reaction, however, has to
be then very quickly down-regulated, since during
the early post implantation phase it is abortogenic.
There are many other cytokines that we will not
discuss here, for sake of space, but we cannot not
mention here CSF-1 and its receptor, whose pro-
gramme is very parallel to what is seen in rodents
and which has a similar role,97-11 mainly as pla-
cental trophoblast growth factor acts as the other
immunotrophic cytokine, IL-3lz In this commu-
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TABLE 3. Endometrial HILDA/LIF production index in women whose last reproductive event was a
pregnancy loss
Last
HILDA/LIF Number of successful Number of Last
production Cycle Age successful pregnancy pregnancy pregnancy
index day (years) pregnancies (years) losses loss (years)
0.98
.12
.20
.79
.86
.89
.98
2.33
2.38
2.43
2.45
2.79
15 38 0 12
15 31 0 4
19 34 2 II 2 3 and 2
9 35 0 2 2
6 33 0 16
20 34 0 4
13 36 3 3
19 38 2 6 4
19 41 2 13
22 32 0 2 3
12 35 0 >20 0.5
14 41 5 3
aMedian 1.94.
From: Delage G, Moreau J-F, Taupin J-L, et al.: In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant
cultures from fertile and infertile women. Hum Reprod 10:2483-2488, 1995.
TABLE 4A. Endometrial HILDA/LIF production index in infertile women with recurrent implantation failure
HILDA/LIF Number Last
production Cycle Age of IVF with Number of pregnancy
index day (years) embryos pregnancies (years)
0.96
0.97
0.97
1.01
.22
.41
.49
.68
.69
.70
.74
2.45
10 34 3 (EUP) 15
5 29 20 3 (2 PL, EUP) 5
21 34 8 2 (I EPT, EUP) 4
6 34 2 I(PL) 9
15 35 3 0
10 39 0
18 33 2 0
9 36 6 0
21 36 2 0
7 34 4 0
14 33 4 (EUP) 10
18 38 6 0
aMedian 1.45.
bplUs GIFT.
EUP extrauterine pregnancy; PL pregnancy loss; EPT elective pregnancy termination.
From: Delage G, Moreau J-F, Taupin J-L, et al.: In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant
cultures from fertile and infertile women. Hum Reprod 10:2483-2488, 1995.
nication, however, we would like to mention tau
and placental interferons.
Placental Interferons
Corpus luteum maintenance in ovine does not de-
pend on non-chorionic gonadotropin, but on tro-
phoblastin whose trophoblast secretion occurs in
the periimplantation, also named ovine trophoblast
protein (oTP). It has pleiotropic activities.13,14 It
exerts a wide variety of effects, such as local anti-
viral properties, preparation of the uterus for opti-
mal implantation by promoting 2 5 A synthetase
activity, and local cytostatic properties, making it
an ideal candidate for early immune suppression. It
is likely to be involved in control of the Thl/Th2
balance.1s-8 It is in fact an interferon of the new
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TABLE 4B. Endometrial HILDA/LIF production
index in infertile women with unexplained
primary sterility
HILDA/LIF
production
index Cycle day Age (years)
1.22 12 41
1.28 6 30
1.39 8 30
1.48 6 33
2.70 13 34
aMedian 1.39.
From: Delage G, Moreau J-F, Taupin J-L, et al.: In vitro endometrial
secretion of human interleukin for DA cells/leukaemia inhibitory factor
by explant cultures from fertile and infertile women. Hum Reprod
10:2483-2488, 1995.
tau interferon family. When such trophoblastins
exist, they are constitutively secreted at very high
doses locally by periimplantation trophoblast only
during the periimplantation phase. It is non abor-
togenic (of course, it maintains pregnancy) and non
toxic/cytostatic for trophoblast, which secretes it,
while interferon at high doses is an abortifacient
in a variety of animal models. The quest is still
ongoing for human equivalents, but not conclu-
sively, despite suggestive evidence19, so one
speculates that its functions could in fact be ex-
erted by omega interferons.
Th I/Th2 BALANCE AND LOCAL
IMMUNOSUPPRESSION
As soon as one completes the implantation period,
in humans and in mice, an abnormal Thl reaction
to trophoblast causes early pregnancy loss, recur-
rent spontaneous abortion, and infertility. Several
mechanisms are involved. For example, the
HELLP syndrome (hemolysis, elevated liver func-
tion tests, and low platelet counts) is linked to an
elevated IL-12 serum level and possibly an en-
hanced IL-2 level in the serum11,11 of unclear
origin, since despite recent molecular evidence for
the contrary112, no IL-2 is assumed to reside in
decidua and placenta. This is especially important,
since in a variety of animal systems, activated NKs
(by IL-2 or IL-4, e. g, LAKCS), are abortifacient,
and indeed LAKCS can lyse trophoblast cells in
vitro,s4 but not normal NKs or CTls. Thus, there
has been a quest as indeed "built-in" in the "allo-
graft model" for local immunosuppression for the
mechanisms of early pregnancy loss and its control.
The Thl cytokines, be they IL-2, interferon y,
or TNF, are abortifacient in vivo, the latter at any
stage of pregnancy, in abortion-prone and non-
abortion-prone systems 17’113’114’116’117 Interferon /
and TNF act in synergy. Their control is exerted
by a variety of non-cytokinic mediators (prostaglan-
dins, 1-25 OH dihydroxyl cholecalciferol in the de-
cidua, placental low MW suppresser factors), as
well as by suppressive cytokines such as TJ6 (the
"pregnancy-associated cytokine") which has been
cloned initially in mice. Monoclonals against TJ6
are abortifacient at early stages, and deficient ex-
pression of TJ6 is reported to be associated with
pregnancy loss in human, especially if the defect is
on CD 19- and CD S6-positive peripheral and de-
cidual lymphocytes. Such a defect could be predic-
tive of risk of pregnancy loss.s-e Another regu-
lator which is, like TJ6, progesterone dependent is
the progesterone induced blocking factor (PIBF),
secreted by activated T lymphocytes, lee PIBF al-
ters the Thl/Th2 balance towards Th2 and corrects
activators of NKK (poly IC) and natural (CBA x
DBA/2) induced abortion.z3-zs Its expression by
maternal lymphocytes has been shown to correlate
with (perhaps even require) implantation.z6 The
decidua-associated transforming growth factor 13-2
analogue
9 is secreted by uterine non-T, non-B
cells in mice and decidual transforming growth fac-
tor [3-2 secreting cells in humans, lz6 It is a potent
immunosuppressive factor, and it has been re-
ported that its production was defective in women
with repeated miscarriages, lz6 Finally IL-10 is
clearly important, since in animal models preg-
nancy is very obviously a Th2 phenomenon.e7 In
humans, it is secreted by placental trophoblasts and
choriocarcinoma, lzs,z9 and, interestingly, its secre-
tion is enhanced by GM-CSF. IL-10 is also pro-
duced by isolated decidual cells.3 In mice, its se-
cretion is more controversial,l’e But, in murine
models, IL-10 with IL-3 suppress local action of
IL-2 and gamma interferon, biasing the maternal
immune response towards a Th2 profile. Deneys
(UCL, Bruxelles, Belgium) has shown that in preg-
nant women, TNF was down-regulated and IL-4
up-regulated when measured in the serum, a pat-
tern not seen in recurrent aborters (Deneys, per-
sonal communication). Further proof of the role of
IL-10 is the effect observed in infections. Leish-
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mania biases the responses towards Thl, and there
is less IL-10 but more pregnancy failure. 133,134
EFFECTOR MECHANISMS
What are the exact mechanisms of early pregnancy
loss? It is clear that interferon and gamma inter-
feron are involved, very often as a consequence of
either abnormal maternal recognition of the con-
ceptus/semen, or local, undetected "a trs bas bruit"
infection, with peculiar insistence on myco-
plasma. 17,18,133-136 The data of Hill strongly sug-
gest it is also the case in humans, e.g., Thl immu-
nity causes recurrent abortions and sterility, with
emphasis on gamma interferon. 137,138 But what are
the exact mechanisms?
First, the cells and the "immunological events"
need to be reconsidered, even for immunotro-
phism; interest is leaning now toward NKs rather
than T cells. Anne Croy has shown that placentae
of NK-deficient mice are grossly hypotrophic, lead-
ing to premature foetal death, 139 shifting t.he "im-
munotrophic" paradigm from T cells to NK cells.
Thus, the production of immunotrophic cytokines
might be in fact mostly (but not exclusively) under
direct control of NK cells more than T cells, and
"allorecognition" of pregnancy might, in fact, be
exerted by these NKs rather than in a classical fash-
ion by T cells. In consequence, a hitherto little
suspected role could be envisaged for HLA-G: the
control of the production of immunotrophic cyto-
kines and not solely the local defusing of NK me-
diated cytolytic functions (a role that was fore-
casted by Y W Loke31).
In the CBA x DBA/2 model of natural immune
abortion, together with the poly IC 12 U model, (an
NK activator),4z we explored the role of NKs in
cooperation with P. Kourilsky.4,43,44 Anti MHC
H-2d (BALB/c) alloimmunisation prevents the ef-
fect of Poly IC or Poly I Poly C12 U as well as CBA
x DBA/2 fetal loss. But, not all selective alloimmu-
nisation prevents the CBA x DBA/2 foetal loss, and
the genetic patterns of the effective immunising
splenocytes (MHC restricted, minor loci depen-
dent), albeit apparently representing a single
trait, lz,41 are so odd to comprehend in terms of
"classical" T-cell recognition (BALB/c works in
CBA xDBA/2, B10,D2 does not-both are H-2d) that
some T-cell and MHC proponents preferred to dis-
miss the data as non reproducible (which they were
not, being reproduced at present by more than 20
labs, with significant developments) or (we quote)
"absolute bullshit."
But, we then demonstrated that immunisation
with Kd or Ld transfected L cells prevented re-
sorptions and used that system to study the effect
ofamino acid mutations on the border of the
pocket of the MHC molecule in that system.
These were shown to affect recognition by mater-
nal cells promoting optimal foetal survival when
immunisation was performed using H-2d mutant
transfected L cells. We then used various muta-
tions that were artificially induced and localized on
the border of the molecule’s groove or in the pep-
tide binding site. Some H-2d mutations on the he-
lixes are recognized as foreign to H-2d and afford
foetal protection against Poly IC. With P. Kouril-
sky, we wondered whether NK recognition of dis-
crete determinants on the MHC molecule was not
involved and, with help of Sylvie Delassus, Jean
Pierre Abastado, Claude Roth, and Jos Even, we
immunised CBA/J with L cells transfected with
H-2d molecules mutant on positions 65, 69, which
do not affect peptide presentation and 114 as a
control. These protected against CBA x DBA/2 fe-
tal loss, and, more important, enhanced IL-10 pro-
duction in the supernatant of placental and de-
cidual explants as already described using a com-
mercial ELISA of high sensitivity, while treatment
with asialo GM1 abolishes this effect.
At this stage, we propose the following working
hypothesis: the NK cell repertoire is heteroclitic
and consists of the recognition of selected altered
domains of MHC molecules, whether that alter-
ation results from mutations or allosteric conforma-
tional changes induced by (in the context of) back-
ground genes. Such a recognition either switches
lytic/cytostatic pathway (macrophage activation,
NK activation, TNF secretion, and balance of the
CD4 system towards a Thl profile) to IL-4 and
IL-12 secretion by the NKs or pushes the system
towards IL-10 secretion, and secretion by NKs or
under the influence of NKs of the so-called "im-
munotrophic" cytokines. Thus, the concept would
integrate both immunotrophism and the Thl/Th2
balance.
As far as the effector mechanisms are involved,
it is already well known that TNF and interferon
are causative and act in synergy,8,4s,146 but other
mediators have been implied, such as nitric oxide
released by activated macrophages.
47-1s There is
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TABLE 5. Role of asialo GMI + NK cells and macrophages in abortions
Day 6.5 Day 7.5 Day 13.5 N
Expt treatment treatment assay resorptions/total % abortions
3. ctrl
ctrl
SiO2
SiO2
PBS PBS 8 23/56 4 I%
PBS 1000 TNF-a 8 43/60 72%
PBS 2000 TNF-c 8 57/64 89%
anti-asialo GM PBS 8 10/59 19%
anti-asialo GM 1000 TNF-c 8 12/63 16%
anti-asialo GM 2000 TNF-c 8 12/55 22%
PBS PBS 16 43/101 43%
PBS 1000 /-IFN 16 79/93 85%
PBS 1000 /-IFN + TNF-c 16 74/89 83%
anti-asialo GM PBS 16 I/71 15%
anti-asialo GM 1000 /-IFN 16 12/98 12%
anti-asialo GM 1000 /-IFN + TNF-c 16 89/104 86%
PBS 8 36/88 41%
/-IFN + TNF-c 8 65/80 81%
PBS 8 14/55 25%
/-IFN + TNF-a 8 52/65 80%
aN represents number of pregnant mice per group.
bSignificant increase in abortion rate, P < 0.005 by X2.
cSignificant increase in abortion rate compared to PBS control, P < 0.005 by 2; significant difference compared to lower dose of TNF-c, P < 0.05.
dSignificant reduction in abortion rate by anti-asialo GMI antibody compared to PBS control, P < 0.005 by X2.
eNo significant boosting of abortion rate compared to PBS injected anti-asialo GMI-treated group.
fResult from two independent experiments giving same result have been pooled.
g/-interferon (--IFN) significantly boosted abortion rate, P < 0.005 by X2.
hTNF-c was given at 1000 v and 2000 in separate experiments with /-IFN and gave similar results; the data have been pooled for ease of presentation.
The abortion rate was significantly boosted, P < 0.005 by X2.
Untreated CBA/J female mice mated to DBA/2 males.
i1000 v /-IFN + 2000 TNF- significantly boosted abortion rate, P < 0.005 by X2.
kCBA/J mice injected twice a week for 4 weeks with 100 mg/kg silicon dioxide before mating significantly reduced abortion rate, P < 0.05 by X2.
no doubt that asialo GMI+ cells or cells of the NK
lineage are involved, since their transfer, once ac-
tivated, causes abortion, and, since they do accu-
mulate at the site of embryo resorption, their
modulation positively (Poly IC activation) or nega-
tively (anti-asialo GM1 treatment) influences par-
allel resorption rates, lsl-1s4 We have studied this
problem with David Clark, taking into account the
fact that TNF and gamma interferon arc by them-
selves abortifacients, and performing cell deletion
to learn the cellular mechanism triggered, lss
In Table 5, intraperitoneal injection of TNF-c
enhanced CBA xDBA/2 resorptions, but anti-asialo
GM1 antibody both decreased the background rate
and prevented the action of TNF-o. When we
added /-interferon, it had as expected an abortifa-
cient effect, but that was not seen in NK-cell-
depleted mice, suggesting that the Baines
model149’1s (-interferon macrophages activated
to produce NO embryo death was not correct.
However, when /interferon and TNF-o were ad-
ministered together, more than 80% of the im-
planted embryos aborted. This confirmed the al-
ready observed syncrgy/codependencc and sug-
gested that in fact it might be crucial. Indeed, NK
cell depletion suggested that TNF-o could not
find enough NK-derived /-interferon, while /-
interferon alone fails because macrophages which
depend on NK-cell-derived -interferon have and
thus did not produce TNF-o, and the intraperito-
neally injected cytokine does not stimulate TNF-o
production quickly enough.
The action of NKs or macrophage has been at-
tributed to a direct killing of trophoblast. In silica
treated macrophage-depleted mice, the abortion
rate was reduced, but this treatment was ineffective
in TNF-o plus /-interferon treated animals, whose
macrophage depletion was checked by the anti F4/
80+ MoAb. Ovarian failure could have happened
after silica, but this was ruled out since it should
have caused abortions in 100% of cases, and the
results were unaltered hormone replacement
therapy treated animals.
The most logical target appeared to be the ma-
ternal uterine vascular endothelial cell, since the
cytokines stimulate surface expression of procoagu-
lant (flg/2-prothrombinase, which is distinct from
tissue factor) and clotting. Table 6 shows that an-
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TABLE 6. Antibody to fig/2 prothombinase prevents abortions in DBA/2-mated CBA/J mice
Pretreatment Day 7.5 Day 13.5 N
group treatment assay resorptions/total % abortion
Control Rabbit IgG nil 8 21/56 38%
Control Rabbit IgG y-IFN + TNF-c 8 48/55 87%
Rabbit IgG anti-fig/2 nil 9 3/66 4.5%
Rabbit IgG anti-fig/2 y-IFN + TNF-c 9 9/68 13%
aResults from two independent experiments which gave the same result.
l000 y-IFN and 2000 v TNF-c was injected intraperitoneally.
cSignificant increase in abortion rate P < 0.001 compared to no cytokine control group. Fisher’s Exact test.
dSignificant reduction in spontaneous abortion rate P < 0.001 compared to no cytokine control group, Fisher’s Exact test.
eSignificant reduction in abortion rate P < 0.001 compared to cytokine-treated controls, Fisher’s Exact test. No significant difference compared to
anti-flg/2-treated mice which did not receive an injection of cytokines.
tibody to fig/2 prothrombinase reduced the back-
ground rate of abortion to 4% and prevented the
effects of TNF-ot plus y-interferon. Since granulo-
cytes are observed in resorption sites and lyse of
TNF-ot plus -interferon-activated endothelial
cells, we tested the injection of pregnan’t mice with
a monoclonal anti-granulocyte antibody which is
known to block granulocyte-mediated tumor rejec-
tion in vivo. ls6 Anti-granulocyte antibody .partially
reduced the spontaneous abortion rate and signifi-
cantly abrogated the effect of TNF-ot plus y-
interferon (as control, see effects of rlL-10) (Table
7). Thus, vasculitis, rather than a direct cytotoxic
action on fetal trophoblast, leads to abortion.
In this context, and in keeping with the afore-
mentioned r61e ofNK cells in cytokine production,
concerning protection against abortion, TGF-132-
producingy T cells in the uterine lining appear to
be important. 1sT,is8 These cells are producing
TGF-[32 and IL-10, albeit, by in situ and immuno-
histochemistry, we find IL-10, IL-3, and IL-4 in
murine spongiotrophoblast mainly, with traces in
the decidua (Cayol, DEA Paris 7, Sept 1997, and in
preparation; See also photos 1,2, and 3), in agree-
ment with what is reported in humans, lzS,lz9
STRESS-INDUCED ABORTION
In a series of models, we have studied stress-
induced abortion. Stress (be it contention, ultra-
sonic stress, etc.) can induce abortion in mice, and
this can be prevented by alloimmunisation. 14s This
phenomenon has been studied in detail. It involves
pathways which are by some aspects very similar to
those discussed above but involving substance P,
CD8 T cells, and alterations of mast cells. The
discussion of stress-induced pathways could be by
itself a review, and readers should refer to other
published papers, lsS-16s
This model is of importance in discussing early
human pregnancy loss. Of interest is the fact that a
monoclonal antibody, BA 11, prepared by R. Jalali
in James Mowbray laboratory, blocks both classical
and stress-mediated abortion. 166,167
To finish, we would like to say we do not negate
systemic events, we simply relativise them. As
stated at the beginning of this paper, we do not
negate the existence of allograft enhancement dur-
ing pregnancy, nor peripheral T-cell hyporespon-
siveness.26-29’67’168-170 We merely believe they re-
flect local events, for the most part, including the
hitherto undiscussed placental suppresser factors.
These, that we have suspected since 1980,171 have
proved to be elusive, 17z-174 but with a continuous
effort in mice, 17s-18z we have delineated the active
moiety in human and murine placental superna-
tants, and this induces T-cell anergylsl,lsz in a very
similar manner to staphyloccocal enterotoxin, 183
explaining, in our view, the T-cell unresponsive-
ness observed locally184 whose aforementioned
phenomenons (especially the report by TafurizT)
are in our opinion a mere reflection. In that respect,
since the anergy is transient and reversible, it is
interesting to note that optimal secretion of the
factor in mice is seen by cells of the invasive
ECP, 17z and that there is a local deficiency in sup-
presser materials in the CBA x DBA/2 window of
abortion.73
CONCLUSIONS
There are several causes of early pregnancy loss,
which we are only beginning to uncover. Several, as
in the murine system, have different etiologies, but
use a final "rejection-like" common pathway,
where TNF and gamma interferon are important.
But several others are likely to be due to NK failure
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TABLE 7. Effect of anti-granulocyte antibody on abortion rate
Day 6.5 Day 7.5 Day 13.5 N
Group treatment treatment assay resorptions/total % abortion
Control rat IgG PBS 8 17/57 30%
2 Rat anti-granulocyte PBS 6 7/45 16%
3 Control rat IgG TNF- + y-IFN 9 48/56 86%
4 Rat anti-granulocyte TNF-c + y-IFN 7 8/57 14%
5 rlL-10 rlL-10 5 2/42 5%
aMonoclonal isotype control IgG 100 mg intraperitoneally as in Materials and Methods.
bLow endotoxin rat monoclonal IgG 100 mg intraperitoneally as in Materials and Methods.
CReduction in abortion rate compared to group I, P 0.072 by Fisher’s Exact test.
dTNF-a + y-IFN given as in Tables and 2. Significant increase in abortion rate compared to group I, P < 0.001 by X and Fisher’s Exact test.
eSignificant reduction in abortion rate compared to group 3, P < 0.001 by2 and Fisher’s Exact test. Pooled result from groups 2 and 4, 15/102 15%
abortion rate, significantly less than 30% rate in group I, P < 0.05 by X2.
fSignificant reduction in abortion rate compared to group I, P < 0.0012 by Fisher’s Exact test. No significant reduction compared to group 2 (P 0.096)
or pooled groups 2 and 4 (P 0.075).
Clark DA, Chaouat G, Arck P, Mittruecker HW, Levy GA: Cytokine-dependent abortion in CBA X DBA/2 mice is mediated by the procoagulant fig/2
prothrombinase. In press.
Stoppacciaro A, Melani C, Parenza M, et al.: Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor
requires granulocyte-T cell cooperation and T cell-produced interferon y. Exp Med 178:15 I, 1997.
or misrecognition, hence improper cytokine secre-
tion and lack of growth factors.
Several others are due to defects of the local
inflammatory reaction (endometriosis, with preex-
isting high levels ofTNF, is among these), and it is
likely that, as in the LIF system, we will see dis-
crete defects leading to definition of molecular ab-
normalities, with defects in adhesion molecules be-
ing involved.
Thus, early pregnancy loss and recurrent mis-
carriage, though due to "immunological-like" cir-
cuitry, are likely to be split up into different syn-
dromes. It is our opinion in that respect that it is
not at all surprising that only one woman out of 10
or 11 benefits from purely imunologic treatment.
We have to be able to define which women will
benefit by rigorous immunological criteria. (Unfor-
tunately, the leukocyte immunisation saga has lead
to many charlatan, unconscious, or preposterous
theorisations, sometimes with disastrous conse-
quences; women are not guinea pigs nor mice! We
have always wondered what was the real basis for
the MHC linked, disequilibrium antigen, as well as
how a system like the CBA xDBA/2-which was
described as minor loci dependent, MHC re-
stricted and in which the good father (BALB/c) and
the bad father (DBA/2) were both H-2d-could have
been taken as an example of the proof for the need
for absence of HLA homology! This is just an ex-
ample, but we could--and, in fact, we are due tom
write horrid things about anti-paternal antibodies,
to illustrate what was said at this paper’s onset.)
This has to be said, because otherwise what we
learn from the discoveries of complex cytokine net-
works at present is that by unfounded treatments
we are at risk of altering other useful pathways and
induce the lack of remission of transient infertility.
The "stress" saga tells us about the importance
of neuroimmunoendocrine pathways, which also
should not be a surprise.
To the impatience of clinicians, we recall what
H. Metzger said when he was cloning the IgE re-
ceptor: "Haste is waste." We believe we have
made significant progress in the past five years in
understanding, with the help ofanimal models, in un-
raveling pathways which are operational indeed.
But, ae nowa have to tabe into account that added
levd of complexity. We know it sounds difficult for
clinicians, because we have a jargon, but we cannot
escape the truth. Yes, a cytobine netaor/ is operating
in early pregnancy, and, in certain cases, we might be
found guilty if we were treating patients as if ig-
noring its existence.
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